News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,409 Results
Type
Article (85964)
Company Profile (303)
Press Release (753142)
Multimedia
Podcasts (103)
Webinars (11)
Section
Business (232106)
Career Advice (4087)
Deals (39688)
Drug Delivery (118)
Drug Development (90792)
Employer Resources (191)
FDA (17997)
Job Trends (17303)
News (395420)
Policy (39648)
Tag
Academia (2994)
Accelerated approval (5)
Adcomms (22)
Allergies (78)
Alliances (56668)
ALS (91)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (147)
Approvals (18001)
Artificial intelligence (239)
Autoimmune disease (24)
Automation (14)
Bankruptcy (403)
Best Places to Work (12474)
BIOSECURE Act (12)
Biosimilars (100)
Biotechnology (247)
Bladder cancer (74)
Brain cancer (27)
Breast cancer (259)
Cancer (2027)
Cardiovascular disease (189)
Career advice (3497)
Career pathing (18)
CAR-T (164)
Cell therapy (420)
Cervical cancer (18)
Clinical research (73013)
Collaboration (726)
Compensation (344)
Complete response letters (24)
COVID-19 (2819)
CRISPR (52)
C-suite (191)
Cystic fibrosis (101)
Data (2103)
Decentralized trials (1)
Denatured (30)
Depression (49)
Diabetes (244)
Diagnostics (6736)
Digital health (13)
Diversity (6)
Diversity, equity & inclusion (48)
Drug discovery (113)
Drug pricing (115)
Drug shortages (15)
Duchenne muscular dystrophy (102)
Earnings (95893)
Editorial (30)
Employer branding (24)
Employer resources (160)
Events (128310)
Executive appointments (556)
FDA (19171)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (668)
Gene editing (114)
Generative AI (21)
Gene therapy (315)
GLP-1 (792)
Government (5076)
Grass and pollen (4)
Guidances (137)
Healthcare (20714)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (120)
Indications (26)
Infectious disease (2938)
Inflammatory bowel disease (151)
Inflation Reduction Act (12)
Influenza (37)
Intellectual property (84)
Interviews (805)
IPO (17640)
IRA (51)
Job creations (5180)
Job search strategy (2848)
Kidney cancer (7)
Labor market (24)
Layoffs (538)
Leadership (12)
Legal (10041)
Liver cancer (72)
Lung cancer (285)
Lymphoma (138)
Machine learning (7)
Management (60)
Manufacturing (236)
MASH (78)
Medical device (14424)
Medtech (14427)
Mergers & acquisitions (22254)
Metabolic disorders (690)
Multiple sclerosis (80)
NASH (22)
Neurodegenerative disease (96)
Neuropsychiatric disorders (31)
Neuroscience (2006)
NextGen: Class of 2025 (7570)
Non-profit (5056)
Now hiring (38)
Obesity (364)
Opinion (256)
Ovarian cancer (74)
Pain (80)
Pancreatic cancer (70)
Parkinson's disease (149)
Partnered (15)
Patents (209)
Patient recruitment (105)
Peanut (48)
People (64730)
Pharmaceutical (51)
Pharmacy benefit managers (15)
Phase I (22584)
Phase II (31716)
Phase III (23884)
Pipeline (1275)
Policy (123)
Postmarket research (3543)
Preclinical (10211)
Press Release (72)
Prostate cancer (96)
Psychedelics (37)
Radiopharmaceuticals (261)
Rare diseases (372)
Real estate (7382)
Recruiting (72)
Regulatory (26462)
Reports (51)
Research institute (2641)
Resumes & cover letters (645)
Rett syndrome (5)
RNA editing (7)
RSV (33)
Schizophrenia (78)
Series A (127)
Series B (80)
Service/supplier (2)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (162)
Sponsored (33)
Startups (4285)
State (1)
Stomach cancer (9)
Supply chain (40)
Tariffs (31)
The Weekly (71)
Vaccines (679)
Venture capitalists (35)
Weight loss (255)
Women's health (29)
Worklife (16)
Date
Today (191)
Last 7 days (792)
Last 30 days (2757)
Last 365 days (26821)
2025 (9762)
2024 (33328)
2023 (42566)
2022 (53928)
2021 (58723)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (56)
Alaska (7)
Arizona (230)
Arkansas (9)
Asia (49787)
Australia (8791)
California (5338)
Canada (1701)
China (455)
Colorado (237)
Connecticut (211)
Delaware (151)
Europe (114040)
Florida (721)
Georgia (188)
Idaho (63)
Illinois (514)
India (19)
Indiana (255)
Iowa (5)
Japan (120)
Kansas (114)
Kentucky (14)
Louisiana (6)
Maine (65)
Maryland (759)
Massachusetts (4265)
Michigan (179)
Minnesota (356)
Mississippi (1)
Missouri (44)
Montana (22)
Nebraska (25)
Nevada (47)
New Hampshire (66)
New Jersey (1516)
New Mexico (25)
New York (1447)
North Carolina (968)
North Dakota (9)
Northern California (2449)
Ohio (188)
Oklahoma (13)
Oregon (33)
Pennsylvania (1161)
Puerto Rico (10)
Rhode Island (23)
South America (1649)
South Carolina (21)
Southern California (1968)
Tennessee (73)
Texas (707)
United States (20359)
Utah (116)
Virginia (125)
Washington D.C. (46)
Washington State (514)
West Virginia (1)
Wisconsin (39)
839,409 Results for "red queen therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Red Queen Therapeutics Announces Expanded Licensing Agreement, Progress in Its Pan-Influenza Program
December 3, 2024
·
4 min read
Press Releases
Apple Tree Partners Launches Red Queen Therapeutics to Bring Potentially Lifesaving Treatments to People at Greatest Risk from Viral Infections
August 6, 2024
·
7 min read
Press Releases
Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center
February 19, 2025
·
2 min read
Press Releases
ArtBlood Signs MOU with Expression Manufacturing for Large-Scale In Vitro Red Blood Cell Production
April 9, 2025
·
4 min read
Press Releases
Red Nucleus Announces Acquisition of Coeus
February 4, 2025
·
3 min read
Genetown
Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
April 23, 2024
·
1 min read
Press Releases
Initiation of ReDS-SAFE HF II Trial for Advancing Heart Failure Management
February 24, 2025
·
3 min read
Press Releases
Red Biotechnology Market to Worth USD 680.7 Billion by 2034
February 12, 2025
·
1 min read
Business
Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)
Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics.
April 10, 2023
·
5 min read
Red Biotechnology Market is Expanding US$ 649.31 Billion by 2033
The global red biotechnology market was evaluated at US$ 385.01 billion in 2023 and is expected to attain around US$ 649.31 billion by 2033, growing at a CAGR of 5.36% from 2024 to 2033.
May 28, 2024
·
9 min read
1 of 83,941
Next
